For what it is worth, since Section 4) Issuer's Business, Products and Services is 3-7 years out of date, the only mention of Canada (via word search), in 1Q24 financial report, is:
On January 1, 2018, the Company entered into a licensing agreement with SSP Asset Management Corp., an organization incorporated under the laws of Alberta, Canada (“SSP”). The license granted SSP the right to use the Company’s transdermal technology for use within certain products. The Company will receive Fifty Percent (50%) of the net profits of any products sold by SSP. The term of the license is 25 years and is exclusive for a minimum of two years on any new products developed by SSP. The Company also issued 20 million restricted common shares to the shareholders of SSP to assist in the development of the new products.
News 
Market Data 
Discover 
